1 | CCNL1, CCNL2, CDK11A, CDK11B
|
| Characterization of cyclin L1 and L2 interactions with CDK11 and splicing factors: Influence of cyclin L isoforms on splice site selection.
|
| Loyer P, Trembley JH, Grenet JA, Busson A, Corlu A, Zhao W, Kocak M, Kidd VJ, Lahti JM.
|
| J Biol Chem [Epub ahead of print] 2008
|
2 | CCNL2
|
| Characterization of cyclin L2, a novel cyclin with an arginine/serine-rich domain: phosphorylation by DYRK1A and colocalization with splicing factors.
|
| de Graaf K, Hekerman P, Spelten O, Herrmann A, Packman LC, Büssow K, Müller-Newen G, Becker W.
|
| J Biol Chem 279(6):4612-24. Epub 2003 Nov 17.
2004
|
3 | CCNL2
|
| Cyclin L2, a novel RNA polymerase II-associated cyclin, is involved in pre-mRNA splicing and induces apoptosis of human hepatocellular carcinoma cells.
|
| Yang L, Li N, Wang C, Yu Y, Yuan L, Zhang M, Cao X.
|
| J Biol Chem 279(12):11639-48. Epub 2003 Dec 17.
2004
|
4 | CCNL2
|
| Patterns of gene expression along the crypt-villus axis in mouse jejunal epithelium.
|
| Cheng H, Bjerknes M.
|
| Anat Rec 244(1):78-94. 1996
|